Susquehanna International Group’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-286,180
| Closed | -$40.1K | – | 6825 |
|
2024
Q1 | $40.1K | Buy |
+286,180
| New | +$40.1K | ﹤0.01% | 5201 |
|
2023
Q4 | – | Sell |
-98,543
| Closed | -$17.3K | – | 6819 |
|
2023
Q3 | $17.3K | Buy |
98,543
+23,175
| +31% | +$4.06K | ﹤0.01% | 5286 |
|
2023
Q2 | $235K | Buy |
75,368
+61,360
| +438% | +$191K | ﹤0.01% | 4480 |
|
2023
Q1 | $35.9K | Sell |
14,008
-1,175
| -8% | -$3.01K | ﹤0.01% | 5508 |
|
2022
Q4 | $22.6K | Sell |
15,183
-10,893
| -42% | -$16.2K | ﹤0.01% | 5343 |
|
2022
Q3 | $45K | Sell |
26,076
-4,202
| -14% | -$7.25K | ﹤0.01% | 5527 |
|
2022
Q2 | $39K | Sell |
30,278
-29,546
| -49% | -$38.1K | ﹤0.01% | 5302 |
|
2022
Q1 | $142K | Sell |
59,824
-86,314
| -59% | -$205K | ﹤0.01% | 5005 |
|
2021
Q4 | $671K | Buy |
+146,138
| New | +$671K | ﹤0.01% | 3407 |
|